| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.05 |